These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 7587995)

  • 1. Carvedilol for hypertension.
    Drug Ther Bull; 1995 May; 33(5):39-40. PubMed ID: 7587995
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carvedilol].
    Antepohl W; Herzig S; Böhm M
    Dtsch Med Wochenschr; 1997 Jun; 122(25-26):833-4. PubMed ID: 9244672
    [No Abstract]   [Full Text] [Related]  

  • 3. How safe is carvedilol in NIDDM patients with hypertension?
    Choudhury D; Misra A
    Natl Med J India; 1998; 11(3):130-1. PubMed ID: 9707705
    [No Abstract]   [Full Text] [Related]  

  • 4. Carvedilol.
    Frishman WH
    N Engl J Med; 1998 Dec; 339(24):1759-65. PubMed ID: 9845712
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of salt intake on the antihypertensive effect of carvedilol.
    Ruilope LM; Lahera V
    J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the Logic of Antihypertensive Therapy: An International Symposium on Carvedilol. Paris, France, October 19, 1990.
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S1-67. PubMed ID: 8098063
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of carvedilol, slow-release nifedipine, and atenolol in the management of essential hypertension.
    Hall S; Prescott RI; Hallman RJ; Dixon S; Harvey RE; Ball SG
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S35-8. PubMed ID: 1721977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with carvedilol.
    Moser M
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S16-20. PubMed ID: 8098064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of carvedilol in severe hypertension.
    Ogihara T; Yoshinaga K; Kamahara Y; Ikeda M; Goto Y; Arakawa K; Iimura I; Ishii M; Kokubu T; Takeda T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S69-72. PubMed ID: 1721983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
    Fardoun RZ
    Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol: a new approach to antihypertensive therapy. Proceedings from International Symposium on Carvedilol. Berlin, March 14-17, 1991.
    Clin Investig; 1992; 70 Suppl 1():S1-131. PubMed ID: 1350477
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial.
    Galioto A; Angeli P; Guarda S; Burra P; Zanus G; Fasolato S; Fagiuoli S; Sticca A; Semplicini A; Sartori M; Carraro A; Boccagni P; Cillo U; Gatta A
    Transplant Proc; 2005 Mar; 37(2):1245-7. PubMed ID: 15848684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of low dose carvedilol on circadian variation of blood pressure in patients with essential hypertension.
    Ogihara T; Ikeda M; Goto Y; Yoshinaga K; Kumahara Y; Iimura O; Ishii M; Murakami E; Takeda T; Kokubu T
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S108-12. PubMed ID: 2454355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
    Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol for portal hypertension in patients with cirrhosis.
    Bosch J
    Hepatology; 2010 Jun; 51(6):2214-8. PubMed ID: 20513005
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertension in the spectrum of cardiovascular disease.
    J Hypertens Suppl; 1993 Jun; 11(4):S1-89. PubMed ID: 8104237
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
    Ozbilen S; Eren MA; Turan MN; Sabuncu T
    Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian antihypertensive profile of carvedilol (BM 14190).
    Meyer-Sabellek W; Schulte KL; Distler A; Gotzen R
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S119-23. PubMed ID: 2454357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: results of a controlled clinical trial.
    Galioto A; Semplicini A; Zanus G; Fasolato S; Sticca A; Boccagni P; Frigo AC; Cillo U; Gatta A; Angeli P
    Liver Transpl; 2008 Jul; 14(7):1020-8. PubMed ID: 18581464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.